Omega-3 and Vascular Disease

by Pat Robinson

· Published Jun 12, 2012 · 3 min read · Sources

0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

4,782 views

This article is copyrighted by GreenMedInfo LLC, 2012

Visit our Re-post guidelines

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.

Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients.
Omega 3 fatty acids improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity.
Omega-3 in modest doses reduces cardiac deaths, and in high doses reduces nonfatal cardiovascular events.
Dietary supplementation with omega-3 fatty acids reduces the incidence of sudden cardiac death in patients with myocardial infarction.
Omega-3 fatty acid reduce the total mortality and sudden death in patients with left ventricular systolic dysfunction.
Raising blood levels of omega-3 fatty acid levels may be 8 times effective than distributing automated external defibrillators (AEDs), and 2 times more effective than implanting implanting cardioverter defibrillators (ICDs) in preventing sudden death
Omega-3 fatty acid supplementation reduces total mortality and sudden death in patients who have already had a heart attack.
Consuming small quantities of fish is associated with a reduction in coronary heart disease.
Omega-3 fatty acids and vitamin D supplementation results in a substantial reduction in coronary calcium scores and slowed plaque growth.
Omega-3 fatty acids improve macro- and microvascular function in subjects with type 2 diabetes mellitus.
Fish oil improves tubular dysfunction, lipid profiles and oxidative stress in patients with IgA nephropathy.
In patients with stable coronary artery disease, an independent and inverse association exists between n-3 fatty acid levels and inflammatory biomarkers.
Omega-3 fatty acids improve endothelial function in peripheral arterial disease.
Fish oil has a beneficial effect on blood viscosity in peripheral vascular disease.
Fish oil supplementation improves walking distance in peripheral arterial disease.
The omega-3 fatty acid docosapentaenoic acid (DPA)reduces the risk of peripheral arterial disease associated with smoking.
Fish and long-chain omega-3 fatty acid intake reduce the risk of coronary heart disease and total mortality in diabetic women.
Higher plasma concentrations of EPA and DPA are associated with a lower risk of nonfatal myocardial infarction among women.
Omega-3 fatty acid consumption is inversely associated with incidence of hypertension.
Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction.
The consumption of fish reduces the risk of ischemic stroke in elderly individuals.
Fish consumption reduces the risk of ischemic stroke in men.
Eicosapentaenoic acid (EPA) may have a therapeutic role in attenuating pulmonary hypertension.

Did you like this information? You can download a PDF with 319 studies relevant to 250+ health benefits associated with Omega-3 fatty acids, linked back to the original citation on the National Library of Medicine, at our downloadable document store. Reminder: Professional and Basic members can download them with their reserve of accumulating GMI-tokens.